Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10054265 | 0.86 | CDK2 (0.31) | — | |
| SCHEMBL29670933 | 0.77 | MEN1 (0.33) | — | |
| SCHEMBL10054269 | 0.77 | MEN1 (0.33) | — | |
| Hydrochloric Acid SCHEMBL28750489 | 0.74 | MEN1 (0.31) | — | |
| Hydrochloric Acid SCHEMBL7049662 | 0.74 | MEN1 (0.31) | — | |
| SCHEMBL10369590 | 0.69 | CYP3A4 (0.37) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL10348051 | 0.69 | — | — | |
| SCHEMBL29463764 | 0.69 | CYP3A4 (0.37) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL690649 | 0.69 | HSD17B10 (0.50) | ALDH1A1CYP1A1CYP1A2CYP3A4HPGD | |
| SCHEMBL9521974 | 0.67 | CD44 (0.32) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120021897-A1 | RING COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-26 | — | — | US | disclosed |
| US-20120021897-A1 | RING COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120021897-A1 | RING COMPOUND | NR4A2, NR4A1, NR0B1 | ALDH1A1 1475/4885CYP1A1 33/4885CYP1A2 37/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.